Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Safe Reversal of Motor and Sensory Deficits by Repeated High Doses of Mesenchymal Stem Cells in a Patient with Chronic Complete Spinal Cord Injury

Safe Reversal of Motor and Sensory Deficits by Repeated High Doses of Mesenchymal Stem Cells in a Patient with Chronic Complete Spinal Cord Injury

Am J Case Rep, 2023 · DOI: 10.12659/AJCR.938576 · Published: May 13, 2023

Spinal Cord InjuryRegenerative MedicineNeurology

Simple Explanation

This case report evaluates the safety and effectiveness of using stem cells from Wharton's Jelly (WJ-MSCs) to treat a patient with a long-term, complete spinal cord injury. The study found the treatment to be safe, with no serious negative effects. The patient experienced improvements in both sensory and motor functions, and reported a better quality of life after receiving the stem cell injections. This suggests that WJ-MSCs could potentially help people with severe, long-lasting spinal cord injuries. Researchers believe the stem cells work by protecting the nerve cells that survived the initial injury, reducing inflammation, and encouraging the regeneration of damaged nerve tissue.

Study Duration
25 Months
Participants
Male, 37-year-old with chronic complete spinal cord injury
Evidence Level
Case Report

Key Findings

  • 1
    The patient's ASIA grade improved from A to C, indicating an improvement in neurological function.
  • 2
    Sensory function improved progressively, as measured by ASIA scores, from 72 to 96 by the end of the study.
  • 3
    The patient regained voluntary anal contraction and partial urinary control, and his Spinal Cord Independence Measure III (SCIM III) score improved from 32 to 57.

Research Summary

This case report details the treatment of a 37-year-old male with a chronic complete spinal cord injury using intrathecal injections of Wharton’s Jelly-derived mesenchymal stem cells (WJ-MSCs). The treatment was found to be safe, with the patient experiencing no serious adverse effects. The patient showed sustained improvements in sensory and motor function, as well as an enhanced quality of life. The findings suggest that WJ-MSCs have the potential to play a significant role in the treatment of chronic and severe spinal cord injuries by protecting neural elements and promoting neuronal regeneration.

Practical Implications

Potential Therapeutic Strategy

WJ-MSCs could be a safe and effective therapeutic strategy for chronic complete SCI.

Future Clinical Trials

The study supports the use of allogeneic MSCs in future clinical trials for patients with severe spine damage.

Mechanism of Action

The observed improvements suggest that WJ-MSCs modulate inflammation, enhance natural healing in the CNS, and promote axonal growth.

Study Limitations

  • 1
    Single case study limits generalizability.
  • 2
    Motor function decline observed during COVID-19 lockdown suggests external factors can influence outcomes.
  • 3
    Lack of a control group makes it difficult to definitively attribute improvements to WJ-MSC treatment.

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury